Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost [PDF]
, 2017 Purpose: To determine variations in cytokine levels of glaucoma patients treated either with preservative-free latanoprost or preserved latanoprost, relative to healthy individuals.
Arriola Villalobos, Pedro +7 more
core +2 more sources
Effectiveness of Latanoprost (Xalatan™) Monotherapy in Newly Discovered and Previously Medicamentously Treated Primary Open Angle Glaucoma Patients [PDF]
, 2005 We evaluated the effectiveness of latanoprost (Xalatan™) monotherapy in primary open angle glaucoma (POAG). Latanoprost is a prostaglandin analogue, the pure 15® epimer of 13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2α- isopropyl ester. As a prodrug it is
Doroteja Pavan-Jukić +6 more
core +3 more sources
Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial. [PDF]
PLoS ONE, 2016 BACKGROUD:To assess the noninferiority of a dorzolamide-timolol fixed combination (DTFC) versus latanoprost in terms of intraocular pressure (IOP) and to compare blood pressure (BP), ocular perfusion pressure (OPP) and diastolic ocular perfusion pressure
Na Young Lee +2 more
doaj +1 more source
Topical latanoprost does not cause macular thickening after uncomplicated cataract surgery. [PDF]
, 2012 PurposeTo explore changes in central macular thickness (CMT) after a two-month period of glaucoma therapy with topical latanoprost after uneventful phacoemulsification.MethodsForty-one eyes of 31 patients with primary open angle or pseudoexfoliative ...
Amini, Heydar +7 more
core +1 more source
Pharmaceutical treatment of primary open angle glaucoma [PDF]
, 2021 Background: Glaucoma is a progressive, irreversible optic neuropathy that results in serious vision loss and blindness. This review aimed to summarize key concepts of primary open angle glaucoma (POAG) pharmaceutical treatment trials over the last decade.
Al-Namaeh , Mashael
core +2 more sources
BMC Ophthalmology, 2012 Background Several studies have investigated the effect of latanoprost on intraocular pressure (IOP). We compared the IOP-lowering effects of three higher concentrations of latanoprost with the commercially available concentration of 0.005% (50 μg/mL) in
Eveleth David +2 more
doaj +1 more source
Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose. [PDF]
, 2018 Background:Topical high-precision piezo-print delivery of microdoses of latanoprost achieved significant IOP reduction consistent with the eyedropper effect but with a 75% reduced exposure to drugs and preservatives.
Ianchulev, Tsontcho +5 more
core
The ever ongoing cosmetic quest to change eye colour
Acta Ophthalmologica, EarlyView.Abstract Purpose To provide a historical overview of the various efforts to change eye colour for purely cosmetic reasons, along with the associated potential risks and harms. Methods Literature and online search. Results Eye drops containing adrenaline were used during World War II on involuntary inmates of concentration camp Auschwitz‐Birkenau ...
Richard H. C. Zegers
wiley +1 more source
Pharmacological mechanisms, clinical effectiveness, and side-effects of prostaglandin analogues as anti-glaucoma agents [PDF]
, 2002 Prostaglandin (PG)-related ophthalmic solutions, which only recently became available for clinical use, are currently the most widely used solutions in the treatment of glaucoma, because they have excellent ocular hypotensive effects with little adverse ...
Kashiwagi, Kenji, Tsukahara, Shigeo
core +2 more sources
Cutaneous and Ocular Toxicology, 2020 Purpose: Latanoprost ophthalmic solution is highly effective as a therapeutic agent for glaucoma and is applied worldwide. However, harmful effects on the corneal surface have been reported regarding the commercially available latanoprost ophthalmic ...
Daisuke Inoue +3 more
semanticscholar +1 more source